Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase NA 1Phase 1 1

Status

Unknown 2Recruiting 2Completed 2

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Head & Neck 6

Conditions

Rectal Neoplasms 13Squamous Cell Carcinoma of Head and Neck 11Esophageal Neoplasms 11Uterine Cervical Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Head and Neck Neoplasms 7Pancreatic Neoplasms 6Oropharyngeal Neoplasms 6Nasopharyngeal Carcinoma 6Carcinoma, Squamous Cell 5Esophageal Squamous Cell Carcinoma 3Carcinoma 3Thymoma 2Stomach Neoplasms 2Neoplasms by Site 2Neoplasms 2NSCLC 2Lymphoma 2Hypopharyngeal Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Adenocarcinoma Of Esophagus 2Urinary Bladder Neoplasms 1Thrombocytopenia 1Small Cell Lung Carcinoma 1Sinonasal undifferentiated carcinoma 1Sinonasal Squamous Cell Carcinoma 1SCLC, Extensive Stage 1Resectable Esophageal Cancer 1Rectal Malignant Neoplasms 1

Interventions

Cisplatin 51Gemcitabine 26toripalimab 20Radiotherapy, Intensity-Modulated 19Fluorouracil 16Capecitabine 16camrelizumab 15Docetaxel 14nimotuzumab 12Radiotherapy 10Drug Therapy 10apatinib 9Nivolumab 9sintilimab 8endostar protein 7Specimen Handling 7Magnetic Resonance Spectroscopy 7Immune Checkpoint Inhibitors 7tislelizumab 6spartalizumab 6Chemoradiotherapy 6Cetuximab 6Bevacizumab 6pembrolizumab 5nedaplatin 5S 1 (combination) 5Radiation 5Paclitaxel 5Endostatins 5anlotinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Nasopharyngeal Carcinoma × Chemoradiotherapy × Clear all
NCT06059261 2026-02-18

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

Chongqing University Cancer Hospital

Phase 2 Recruiting
30 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT04004871 2025-12-11

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

Guangxi Medical University

Phase 2 Completed
60 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT06455410 2024-06-25

GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Recruiting
216 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05520814 2023-09-21

PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial

Sichuan Cancer Hospital and Research Institute

Phase 2 Unknown
50 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT03427359 2018-02-09

Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

The University of Hong Kong-Shenzhen Hospital

Phase 2 Completed
65 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03058432 2017-02-23

Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Zhejiang Cancer Hospital

Phase 2 Unknown
122 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡